Literature DB >> 28369418

Correction of myelotoxicity after switch of linezolid to tedizolid for prolonged treatments.

L Khatchatourian1, A Le Bourgeois2, N Asseray1, C Biron1, M Lefebvre1, D Navas3, M Grégoire4, B Gaborit1, F Raffi1, D Boutoille1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28369418     DOI： 10.1093/jac/dkx097

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Pharmacokinetics of Tedizolid in an Obese Patient after Bariatric Surgery.

Authors:  Matthieu Grégoire; Julia Brochard Libois; Denis Waast; Benjamin Gaborit; Marc Dauty; Guillaume Deslandes; Eric Dailly; Sophie Touchais; David Boutoille; Nicolas Grégoire; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

2.  Tedizolid: a service evaluation in a large UK teaching hospital.

Authors:  Joshua A York; Kate Adams; Lorraine Cullen; Joanne Delahay; Monica Ivan; Patrick J Lillie; Laura MacLachlan; Gavin Barlow
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-08-26       Impact factor: 3.267

3.  Tolerance of Prolonged Oral Tedizolid for Prosthetic Joint Infections: Results of a Multicentre Prospective Study.

Authors:  Eric Senneville; Aurélien Dinh; Tristan Ferry; Eric Beltrand; Nicolas Blondiaux; Olivier Robineau
Journal:  Antibiotics (Basel)       Date:  2020-12-23

4.  Correction of Linezolid-Induced Myelotoxicity After Switch to Tedizolid in a Patient Requiring Suppressive Antimicrobial Therapy for Multidrug-Resistant Staphylococcus epidermidis Prosthetic-Joint Infection.

Authors:  Tristan Ferry; Cécile Batailler; Anne Conrad; Claire Triffault-Fillit; Frédéric Laurent; Florent Valour; Christian Chidiac
Journal:  Open Forum Infect Dis       Date:  2018-09-25       Impact factor: 3.835

5.  Medical management of atraumatic Mycobacterium abscessus cutaneous infection: A case report.

Authors:  Chong Wei Tiong; Thomas Nack; Alex Y C Tai; N Deborah Friedman
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-11-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.